Post patent expiry, numerous Indian companies launched generic versions of Empagliflozin. The market witnessed a surge in brands and player...

Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly reduced prices follo...

Domestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the expiry of Boehrin...

The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...

While they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...

Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...

As volatility increases, the focus in the market is shifting to stocks which are considered as relatively defensive. These stocks tend to f...

BI said the injunctions restrain the domestic pharma companies from infringing the patent of Linagliptin by advertising, launching, making,...

The drugmaker said it is reviewing legal options including filing an appeal against the court order. Dr Reddy's has launched copies of Jard...

In a statement to ET, BI confirmed it has obtained separate orders granting ad-interim injunction that restrains the two domestic pharmaceu...

Earlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.

Under its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim....

Here are a few stocks that are likely to see some action in Monday’s trade.

The drugmaker is one of the two largest manufacturers of hydroxychloroquine (HCQ).

HDFC twins and Reliance Industries were among the biggest drags, but a jump in L&T after three ‘large’ order wins cushion the fall to some ...

JSPL has bagged an order of 2,308 tonne head hardened rails from Kolkata Metro Rail Corporation.

With Jardiance, BI has the advantage of significantly reducing cardiovascular risks associated with most patients with diabetes.